Journal of Urology

Article	Citations
Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology	405
Urological Oncology: Prostate Cancer	380
Editorial Comment	325
This Month in Adult Urology	286
MP06-15 VIRTUAL REALITY IMMERSION FOR REDUCING ANXIETY AND PAIN DURING TRANSPERINEAL PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL	191
MP27-09 OXYMATRINE IMPROVES ERECTILE FUNCTION THROUGH SUPPRESSION OF INFLAMMATION AND FIBROSIS IN DIABETIC RATS	191
MP17-14 IDENTIFYING CRIBRIFORM PATTERN IN MPMRI SCANS FROM 3D RECONSTRUCTED RALP SPECIMENS USING DEEP LEARNING	179
MP40-03 CIRCULATING CHROMOSOME CONFORMATION SIGNATURES ENHANCE THE ACCURACY OF PSA FOR DETECTING PROSTATE CANCER - RESULTS FROM PERFORMANCE OF THE EPISWITCH TM PCA T	165
MP22-04 MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER	158
PD33-08 BACTERIAL BIOFILMS FROM INDWELLING SACRAL NEUROMODULATION DEVICES ARE RECONSTITUTABLE IN VITRO AND EXHIBIT DIFFERENTIAL FORMATION BY MATERIAL TYPE	144
V02-10 LIMITED RESOURCES IMPROVISED BASKETS FOR PCNL	143
MP67-12 FIRST LOOK: LASER SPECKLE IMAGING IS A NOVEL METHOD TO IDENTIFY AND PRESERVE NEUROVASCULAR BUNDLE DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY	117
PD23-04 URINARY PROTEINS IN THE DIAGNOSIS OF MIXED INTRINSIC SPHINCTER DEFICIENCY AND DETRUSOR OVERACTIVITY IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE?	108
PD32-07 RACE MODIFIED ESTIMATED GLOMERULAR FILTRATION RATE UNDERESTIMATES CHRONIC KIDNEY DISEASE PREVALENCE IN AFRICAN-AMERICAN PATIENTS UNDERGOING PARTIAL AND RADICAL NEPHRECTOMY: IMPLICATIONS FOR SU	97
MP64-20 UNDERSTANDING CLINICAL OUTCOMES IN PATIENTS RENDERED NO EVIDENCE OF DISEASE IN METASTATIC RENAL CELL CARCINOMA	83
PD12-11 URETHRAL COMPLICATIONS AFTER METOIDIOPLASTY WITH URETHRAL RECONSTRUCTION	80
PD27-02  99m TC-PSMA RADIOGUIDED SURGERY USING A DROP-IN GAMMA PROBE IN RADICAL PROSTATECTOMY: INITIAL RESULTS	78
PD08-12 PREDICTORS OF PROGRESSION AND DELAYED INTERVENTION IN SMALL RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE WITHOUT HEALTH-RELATED SELECTION BIAS	77
V04-06 ROBOTIC ASSISTED TRANS-VESICOSCOPIC URETERIC REIMPLANTATION IN CHILDREN: SURGICAL ERGONOMICS RELATED TO MUSCULOSKELETAL SYMPTOMS	71
MP53-20 INITIAL UROLOGIC EVALUATION FOR ANORECTAL MALFORMATIONS: A PCPLC RETROSPECTIVE	70
MP28-03 CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS	69
V07-07 WIRE-GUIDED EXTRAVESICAL ROBOT-ASSISTED BLADDER DIVERTICULECTOMY AND Y-V PLASTY FOR RECURRENT BLADDER NECK STRICTURE	64
LBA01-08 EFFICACY OF TARGETED MAST CELL INHIBITION THERAPY IN CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME	63
PD04-08 BALIXAFORTIDE, A CXCR4 INHIBITOR, SYNERGIZES WITH DOCETAXEL TO DIMINISH TUMOR GROWTH IN A PROSTATE CANCER MODEL OF BONE METASTASIS	58
PD43-02 FUNCTIONAL OUTCOMES AFTER SELECTIVE CLAMPING IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY	55

MP48-04 PERSPECTIVES OF SOCIETY OF WOMEN IN UROLOGY MEMBERS TOWARD DOBBS V. JACKSON WOMEN′S HEALTH ORGANIZATION	54
MP66-14 WEBSITE TRANSPARENCY AND INFORMATION DISSEMINATION AMONG UROLOGY RESIDENCY PROGRAMS	50
MP38-19 FOCAL THERAPY CANDIDACY: AN EVALUATION OF INITIAL AND CONTINUED ELIGIBILITY FOR FOCAL THERAPY IN AN ACTIVE SURVEILLANCE COHORT	50
PD39-07 CAN WE STOP DOING SYSTEMATIC BIOPSIES IN MEN WITH PIRADS/LIKERT 5 LESIONS ON MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING? AN ANALYSIS FROM A MULTICENTRE PROSPECTIVE DATASET OF OVER 800 PATIENT	49
PD17-03 REDOX IMBALANCE AND MAPK ACTIVATION MEDIATES PNEUMOPERITONEUM-INDUCED KIDNEY INJURY DURING MINIMALLY INVASIVE SURGERY	47
MP57-02 AN UPDATE ON PROFESSIONAL BURNOUT AND CONFLICT-WORK FROM THE AUA WORKFORCE WORKGROUP	47
HF02-04 KEEPING IT REEL: PHOTOGRAPHY AND CINEMATOGRAPHY IN UROLOGY	44
MP30-02 A NOVEL PREDICTION MODEL FOR POSSIBILITY OF SPERM RETRIEVAL IN MICRO TESE FOR NON-OBSTRUCTIVE AZOOSPERMIA PATIENTS USING AUTOMATED ARTIFICIAL INTELLIGENCE	43
PD24-03 BEST TREATMENT FOR OLIGOMETASTATIC RENAL CANCER: A QUASI-INDIVIDUAL PATIENT DATA ANALYSIS	43
MP12-03 IMPLICATIONS OF RACE FREE RENAL FUNCTION EQUATIONS ON BLACK PATIENTS WITH RENAL CELL CARCINOMA	43
MP62-05 AUA RECOMMENDED ANTIBIOTIC PROPHYLAXIS FOR PRIMARY PENILE IMPLANTATION RESULTS IN A HIGHER, NOT LOWER, RISK FOR POST-OPERATIVE INFECTION: A MULTICENTER ANALYSIS	41
MP70-07 HIGH-PERFORMING SCALABLE EXTRACTION OF ELEMENTS OF URINARY TRACT DILATION CLASSIFICATION USING NATURAL LANGUAGE PROCESSING ALGORITHMS FOR NEONATAL ULTRASOUND REPORTS	40
MP36-04 PREDICTORS OF PENILE PLICATION AFTER INTRALESIONAL COLLAGENASE CLOSTRIDIUM HISTOLYTICUM INJECTION IN MEN WITH PEYRONIE’S DISEASE	39
MP36-05 CLINIC SCORE - A NOVEL PREDICTION MODEL OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM OUTCOMES IN MEN WITH PEYRONIE’S DISEASE	39
PD19-09 IMMUNOPROPHYLAXIS WITH AUTOVACCINE DECREASES HOSPITAL ADMISSIONS AND EMERGENCY ROOM VISITS IN PATIENTS WITH NEUROGENIC BLADDER	38
MP41-18 CLINICAL MANIFESTATIONS OF BIRT-HOGG-DUBE SYNDROME IN A LARGE CLINICAL COHORT	37
MP02-03 FASCIOCUTANEOUS FLAP CLOSURE OF THE PERINEUM AS AN ALTERNATIVE TO SCROTOPLASTY FOR EXTENSIVE GENITAL TISSUE LOSS	37
PD14-12 SEXUAL FUNCTION IN WOMEN FOLLOWING TENSION-FREE VAGINAL TAPE-OBTURATOR PROCEDURE: A PROSPECTIVE STUDY	37
PD31-09 DEVELOPMENT OF EXTREME GRADIENT BOOST (XGBOOST) MACHINE LEARNING MODEL USING AN INSTITUTIONAL PEDIATRIC KIDNEY TRANSPLANT DATABASE FOR PREDICTION OF DELAYED GRAFT FUNCTION	36
MP38-07 UPGRADING ON PER PROTOCOL VS FOR CAUSE SURVEILLANCE PROSTATE BIOPSIES: AN OPPORTUNITY TO DECREASING THE BURDEN OF ACTIVE SURVEILLANCE	35
MP33-08 OPIOID PRESCRIBING PATTERNS AND POST-PROSTATECTOMY READMISSION	34
MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER	34
PD51-08 SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA	34
PD47-12 DOES ANESTHESIA TYPE MATTER IN SHOCKWAVE LITHOTRIPSY?	34
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology	33
Reply by Authors	33
PD35-04 OPEN VS. ROBOTIC-ASSISTED RECONSTRUCTION IN VESICOURETHRAL ANASTOMOTIC STENOSIS	33
V02-06 A TECHNIQUE FOR COMBINED ROBOTIC SACROCOLPOPEXY AND VENTRAL MESH RECTOPEXY	32
MP57-13 IS BIPOLAR ENUCLEATION OF THE PROSTATE AN EFFECTIVE AND COST-EFFICIENT ALTERNATIVE TO ROBOTIC SIMPLE PROSTATECTOMY?	32
Editorial Comment	32
MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)	31
PD58-09 GROWTH KINETICS OF ONCOCYTIC NEOPLASMS ON ACTIVE SURVEILLANCE AND IMPACT ON RENAL FUNCTION	30
MP01-10 THE LANDSCAPE OF RACIAL AND ETHNIC DISPARITY IN TESTICULAR CANCER STAGE PRESENTATION: A NATIONAL HOSPITAL-BASED STUDY	30
PD23-09 THE EFFECT OF ADRENALECTOMY ON OVERALL SURVIVAL IN METASTATIC ADRENOCORTICAL CARCINOMA	30
PD61-05 ONCOLOGICAL OUTCOMES OF NEOADJUVANT DEGARELIX WITH APALUTAMIDE (ARNEO TRIAL) VERSUS STANDARD OF CARE PRIOR TO RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PROPENSITY SCORE MATCHED AN	29
MP76-14 PROPHYLACTIC DIPS AND IRRIGATION SOLUTIONS CAN CONSIDERABLY ALTER THE ANTIMICROBIAL EFFICACY OF INFLATABLE PENILE PROSTHESIS HYDROPHILIC SURFACE COATINGS	28
PD47-07 THE STUDY OF AUTOMATIC RECOGNITION OF STONE COMPONENTS USING DIGITAL IMAGES FROM INTRAOPERATIVE FLEXIBLE URETEROSCOPY	28
MP24-16 URETEROSCOPY AT AMBULATORY SURGERY CENTERS CAN BE SAFE FOR CAREFULLY SELECTED HIGH-RISK PATIENTS	28
MP62-13 LONG-TERM MEDICATION USE AFTER SURGICAL TREATMENT FOR BLADDER OUTLET OBSTRUCTION, HOW DOES HOLEP COMPARE TO OTHER SURGICAL MODALITIES?	28
MP34-14 ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY	27
MP32-17 LONG-TERM FOLLOW-UP AND SUCCESS RATE OF VENTRAL INLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY VS DORSAL ONLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY FOR FEMALE URETHRAL STRICTURE DISEASE	27
MP31-07 PROSTATE EXTRACELLULAR VESICLES AND PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A PROSPECTIVE SINGLE-INSTITUTION PILOT STUDY	27
PD14-08 IDENTIFICATION OF A BLADDER CANCER SUBPOPULATION THAT MAY BENEFIT FROM DASATINIB	27
MP02-01 "DOCTOR 1 PUT ME IN TOUCH WITH A FORMER PATIENT... OF MY EXPERIENCE THROUGH IT, I THINK SHE HELPED ME THE MOST": PEER SUPPORT AS AN INVALUABLE RESOURCE IN THE SETTING OF BLADDER CANCER SURGERY	27
MP35-13 PREVALENCE, TRENDS, AND COSTS OF OFFICE-BASED AND AMBULATORY SURGERY CENTER-BASED DIAGNOSTIC CYSTOSCOPY IN THE UNITED STATES	26
MP08-20 SIGNIFICANT DROP OF EARLY AND TWO-YR MORTALITY FOR BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY IN THE LAST 20 YEARS: SINGLE CENTER ANALYSIS	26
PD61-12 SAME-DAY DISCHARGE FOLLOWING ROBOTIC PROSTATECTOMY: STANDARDIZATION AND SAFETY EVALUATION	25
MP21-06 USABILITY TESTING OF THE SET BRAVE GOALS APP, A CONTINENCE GOAL-SELECTION APP FOR CHILDREN WITH SPINA BIFIDA	25
PD55-09 THE BALL IS OUT OF OUR COURT: DOES MODERN PRIMARY CARE LITERATURE REFLECT THE AMERICAN UROLOGICAL ASSOCIATION CRYPTORCHIDISM GUIDELINES?	25
MP76-02 EXPLORING THE EFFECTS OF AMNIOTIC BLADDER THERAPY ON FEMALE SEXUAL DYSFUNCTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS	25

MP70-20 MORTALITY DISPARITIES AMONG ASIAN AMERICANS DIAGNOSED WITH UROLOGIC CANCER	25
MP03-13 ARTIFICIAL URETHRAL SPHINCTER PRESSURE REGULATING BALLOON AND CUFF VARIATIONS FOLLOWING DEVICE EXPLANTATION	25
MP63-07 THE BUTOX STUDY: THE ROLE OF THE GUT MICROBIOME AND BUTYRATE IN CALCIUM OXALATE KIDNEY STONE DISEASE	25
PD28-11 O TO ZZZ's: INVESTIGATING THE RELATIONSHIP BETWEEN ORGASM AND SLEEP QUALITY IN WOMEN	24
V11-11 HUGO RAS SIMPLE PROSTATECTOMY SEC. MILLIN: STEP BY STEP SURGICAL PROCEDURE AND SET UP IN A THREE ARMS CONFIGURATION	24
MP36-11 GERIATRIC NUTRITIONAL RISK INDEX AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH CLEAR-CELL RENAL CELL CARCINOMA	24
MP19-05 LEARNING CURVES OF FUSION-GUIDED BIOPSY AND ULTRASOUND PROSTATE SEGMENTATION: A SINGLE-CENTER STUDY INVOLVING 14 OPERATORS AND 1721 PATIENTS	23
PD28-08 ASSOCIATION OF LOW TESTOSTERONE, FRAILTY, AND POSTOPERATIVE OUTCOMES AMONG MEN UNDERGOING UROLOGIC SURGERY	23
PD31-06 LONG-TERM OUTCOMES AFTER ISOLATED EPISPADIAS REPAIR	23
MP44-05 PARENCHYMAL VOLUME ANALYSIS TO ASSESS LONGITUDINAL FUNCTIONAL DECLINE AND ATROPHY AFTER PN	23
MP43-19 NOVEL NANOPARTICLE COATINGS DEMONSTRATE ANTIBACTERIAL AND ANTIBIOFILM PROPERTIES AGAINST MULTIPLE UROPATHOGENS	23
PD27-01 DEVELOPMENT OF A MACHINE LEARNING (ML) MODEL TO AUTOMATICALLY AND PRECISELY IDENTIFY KIDNEY STONES FROM URETEROSCOPY VIDEO RECORDINGS	23
PD49-07 UTILITY OF TESTICULAR SHEAR-WAVE ELASTOGRAPHY IN THE EVALUATION OF PEDIATRIC PATIENTS WITH KLINEFELTER SYNDROME	23
PD52-01 A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE'S DISEASE: CLINICAL TRIAL UPDATE	22
PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS	22
MP69-05 DEVELOPING AN ANTIMICROBIAL IRRIGATION SOLUTION FOR ENDOUROLOGICAL PROCEDURES: EX VIVO EFFICACY AND IN VIVO SAFETY	22
MP54-17 FOSTERING DIVERSITY IN UROLOGY: ADDRESSING ETHNIC DISPARITIES IN APPLICANT AND RESIDENT RECRUITMENT	22
MP26-04 HOW MIRABEGRON AFFECTS THE HUMAN URETER: AN IN VITRO STUDY	22
PD14-10 ENHANCED ANTITUMOR EFFECT OF THE COMBINATION OF BACILLE CALMETTE-GUÉRIN AND AN IMMUNE CHECKPOINT INHIBITOR IN BLADDER CANCER-ON-A-CHIP	22
MP69-07 UROLOGIC COMPLICATIONS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 (SGLT-2) INHIBITORS DIFFER BETWEEN DIABETIC MEN AND WOMEN	22
PD18-09 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN CONTEMPORARY METASTATIC RENAL CELL CARCINOMA: AN OTHER-CAUSE MORTALITY MATCH POPULATION-BASED STUDY	21
PD55-04 IS PERCUTANEOUS NEPHROLITHOTOMY EFFECTIVE AND SAFE IN INFANTS YOUNGER THAN 2 YEARS OLD? COMPARISON OF MINI AND STANDARD PERCUTANEOUS NEPHROLITHOTOMY?	21
MP29-20 A PROSPECTIVE, SINGLE CENTER RANDOMISED CONTROLLED TRIAL COMPARING DUSTING AND FRAGMENTATION MODES OF THULIUM FIBER LASER IN RETROGRADE INTRARENAL SURGERY	21
MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA	21
PD14-05 THE STROMA-RICH CONSENSUS BLADDER CANCER SUBTYPE CORRELATES WITH IMPROVED PROGNOSIS AFTER NEOADJUVANT IMMUNOTHERAPY AND RADICAL CYSTECTOMY	21
PD33-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH HUGO™ RAS SYSTEM: PERIOPERATIVE OUTCOMES AND TRIFECTA ACHIEVEMENT FROM THE LARGEST MULTICENTRIC SERIES	21
V14-05 ARTIFICIAL INTELLIGENCE-BASED INTRAOPERATIVE GUIDANCE: DEMONSTRATION OF REAL-TIME SEGMENTATION AND FEATURE TRACKING IN ROBOTIC SURGERY	20
PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE	20
MP49-07 DEFINING HIGH GLEASON SCORE PROSTATE CANCER BY PROSTATE FLUID METABOLIC FINGERPRINT BASED MULTI-MODAL DIAGNOSIS	20
MP18-02 DOES DEEP LEARNING RECONSTRUCTION IMPROVE URETERAL STONE DETECTION AND SUBJECTIVE IMAGE QUALITY IN THE CT IMAGES OF PATIENTS WITH METAL HARDWARE?	20
PD05-03 REDUCING EMERGENCY ROOM VISITS THROUGH THE USE OF MULTI-LANGUAGE EDUCATIONAL PAMPHLETS AFTER URETEROSCOPY WITH URETERAL STENT PLACEMENT	20
MP39-14 EVALUATING THE CONTRIBUTION OF THE STANDARDIZED LETTER OF RECOMMENDATION TO A SUCCESSFUL MATCH IN UROLOGY RESIDENCY	20
PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION	20
MP30-15 MACHINE LEARNING TO DISTINGUISH BENIGN AND MALIGNANT RENAL LESIONS BASED ON ROUTINE CT IMAGING	20
MP41-11 CIRCULATING MICRORNA PROFILING FOR PREDICTION OF ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS FOLLOWING RADICAL PROSTATECTOMY	20
MP75-17 EXAMINING THE RELATIONSHIP BETWEEN DIETARY INFLAMMATORY INDEX AND URINARY FLOW RATE: RESULTS FROM A NATIONWIDE STUDY	20
MP79-10 PHARMACOVIGILANCE ANALYSIS OF MELANOMA ADVERSE EVENTS IN MEN TREATED WITH SILDENAFIL FOR ERECTILE DYSFUNCTION	19
MP46-13 ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL PADUA ILEAL NEOBLADDER: LONG-TERM FUNCTIONAL OUTCOMES AND CONTINENCE PREDICTORS ASSESSMENT FROM A HIGH-VOLUME CENTER LARGE CONSECUTIVE SER	19
MP47-03 TRENDS IN SBRT FOR INOPERABLE RENAL CELL CARCINOMA	19
PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESP	19
V08-03 ENDOSCOPIC RESECTION OF AN ENTEROANASTOMOTIC TUMOR RECURRENCE AFTER RADICAL CYSTECTOMY: A NOVEL APPROACH USING BIPOLAR RESECTION	19
PD41-11 THE IMPACT OF PROSTATE VOLUMES (≤80 CC VS. > 80 CC) ON PERIOPERATIVE OUTCOMES AND RISK OF RETREATMENT IN PATIENTS UNDERGOING AQUABLATION: A SINGLE-CENTER STUDY	19
MP72-09 SELF-SCHEDULING IMPROVES QUALITY OF CARE FOR HOSPITAL DISCHARGE FOLLOW UP OF URINARY RETENTION PATIENTS	19
MP70-06 MATCHED ANALYSIS OF URINARY TRACT INFECTIONS AND READMISSIONS AFTER OPEN URETERONEOCYSTOSTOMY: DOES AGE MATTER?	19
MP15-10 DISCOVERY OF TBK1 ASSOCIATED ONCOGENIC MECHANISM WHICH MEDIATES THE UPPER-TRACT UROTHELIAL CARCINOMA WITH PREEXISTING END STAGE RENAL DISEASE	19
MP44-08 RELATIONSHIP BETWEEN COVID 19 VACCINATION AND PSA LEVEL	19
PD08-11 ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1a KIDNEY TUMORS: TWELVE-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY	18
PD25-05 CHRONIC EXPOSURE OF PHYSIOLOGICAL CONCENTRATION OF ARSENIC INDUCED BLADDER MALIGNANCY IN PRECLINICAL MODELS	18
MP71-18 PERIPHERAL TIBIAL NERVE STIMULATION DEMONSTRATES LIMITED IMPROVEMENT IN SELF-REPORTED SYMPTOMS FOR PATIENTS WITH OVERACTIVE BLADDER: SINGLE CENTER EXPERIENCE	18
MP72-17 SURGEON’S PERSONAL OPIOID BEHAVIORS IMPACT POST-OPERATIVE PRESCRIBING FOR OUTPATIENT PROCEDURES	18
MP25-06 DEVELOPMENT OF A MULTI-INSTITUTIONAL, SIMULATION-BASED SURGICAL SKILLS BOOTCAMP FOR JUNIOR UROLOGY RESIDENTS	18
MP61-11 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY AFTER PREVIOUS TRANS-URETHRAL RESECTION OF THE PROSTATE: ASSESSMENT OF FUNCTIONAL AND ONCOLOGICAL OUTCOMES	18
MP05-01 MICRO COMPUTED TOMOGRAPHY ANALYSIS OF MINERAL IN RENAL PAPILLAE SHOWS THAT RANDALL'S PLAQUE FORMATION OCCURS INDEPENDENTLY OF UPSTREAM DUCTAL PLUGGING IN THE MEDULLA	18
PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCA	18
MP15-09 TADALAFIL VERSUS COMBINED TAMSOLUSIN AND CIPROFLOXACIN FOR TREATMENT OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED CONTROLLED TRIAL	18
MP35-11 TRENDS AND INCIDENCE OF REPORTED EVENTS ASSOCIATED WITH URETERAL STENTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION'S MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE DATABASE	18
PD45-03 FACTORS AFFECTING HOLMIUM LASER INEFFICIENCY: COMPARISON OF LARYNGEAL MASK AIRWAY AND ENDOTRACHEAL TUBE USE DURING FLEXIBLE URETEROSCOPY FOR RENAL STONES	17
MP53-05 RISK OF ACUTE KIDNEY INJURY AFTER LOWER URINARY TRACT RECONSTRUCTION WITH EARLY NSAID THERAPY: A PROPENSITY MATCHED RETROSPECTIVE ANALYSIS	17
MP03-19 ROLE OF MICROFIBRILLAR-ASSOCIATED PROTEIN 4 IN PARTIAL BLADDER OUTFLOW OBSTRUCTION-RELATED BLADDER FIBROSIS	17
MP74-18 DETRUSOR VOIDING CONTRACTION VELOCITY IS RELEVANT TO PATIENTS WITHOUT BLADDER OUTFLOW OBSTRUCTION	17
MP58-04 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE FREE-SURVIVAL AFTER PERCUTANEOUS ABLATION FOR CT1 RENAL MASSES	17
MP75-10 SURVIVAL OUTCOMES BY RACE FOLLOWING MINIMALLY INVASIVE SURGICAL TREATMENT FOR UPPER TRACT UROTHELIAL CARCINOMA: AN ANALYSIS OF THE ROBUUST REGISTRY	17
MP06-20 SIGNIFICANT REDUCTION OF PERIOPERATIVE SERIOUS REPORTABLE EVENTS THROUGH A NOVEL SURGICAL SAFETY CHECKLIST AND TIME-OUT PROCEDURE	17
LBA02-12 IS LEARNING CURVE IMPORTANT WHILE PERFORMING PSMA-PET? ANALYSIS OF DETECTION RATE ACCORDING TO GLEASON SCORE AND PSA LEVEL IN TWO TIMEFRAMES AT A BRAZILIAN HIGH-VOLUME CENTER	17
PD24-07 FIRST ANALYSIS OF THE SAFETY AND EFFICACY OF UGN-101 IN THE TREATMENT OF URETERAL TUMORS	17
Prostate Cancer: Markers I (MP41)	16
Pro: Does COVID Affect Male Reproductive Health?	16
Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Non-neurogenic Voiding Dysfunction I (MP74)	16
MP09-16 INFORMING AN APPROACH TO THE SUBCAPSULAR RENAL HEMATOMA (SRH): A TEN-YEAR REVIEW OF THE NATURAL HISTORY AND PROGRESSION OF SRH	16
Reply by Authors	16
Stone Disease: Surgical Therapy (Including ESWL) I (PD01)	16
Prostate Cancer: Detection & Screening I (MP40)	16
Hooman Djaladat, MD, MS	16
Bladder Cancer: Non-invasive III (MP15)	16
Benign Prostatic Hyperplasia: Surgical Therapy & New Technology III (IP19)	16
Benign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy (MP24)	16
HF02-14 HERNIAS, HEALING, HAGIOGRAPHY: AN ANALYSIS OF ST. ARTEMIOS AND BYZANTINE INCUBATION RITUALS	16
Stone Disease: Basic Research & Pathophysiology (MP63)	15
Surgical Technology & Simulation: Instrumentation & Technology (IP11)	15
Editorial Comment	15

Editorial Comment	15
Prostate Cancer: Localized: Active Surveillance (MP38)	15
Bladder Cancer: Invasive VI (MP77)	15
Health Services Research: Practice Patterns, Quality of Life and Shared Decision Making II (MP09)	15
Socioeconomic Factors, Urological Epidemiology, and Practice Patterns	15
Infertility: Epidemiology & Evaluation II (PD18)	15
Editorial Comment	15
Benign Prostatic Hyperplasia: Surgical Therapy & New Technology II (PD08)	15
Male and Female Sexual Function and Dysfunction; Andrology	15
This Month in Adult Urology	15
Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monother	14
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology	14
Benign Prostatic Hyperplasia	14
IP23-07 ANATOMY OF A COMPLICATION: CLINICO-RADIOLOGIC FEATURES OF BLEEDINGS AFTER ROBOTIC-ASSISTED RADICAL PROSTATECTOMY. THE ROLE OF THE OBTURATOR ARTERY VARIANTS	14
PD39-05 NEUROMODULATION OF PELVIC NERVES INCREASES NERVE REGENERATION AFTER INJURY	14
Editorial Comment	14
Editorial Comment	14
Editorial Comment	14
Editorial Comment	14
Editorial Comment	14
Editorial Comment	14
Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI?	14
Imaging	14
Editorial Comment	14
Editorial Comment	14
Imaging Mass Cytometry Immune Profiling of Hunner Lesions in a Convenience Sample of Patients With Interstitial Cystitis/Bladder Pain Syndrome	14
Male Infertility	14
Reply: Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial	14
MP20-07 NPTX1 IS A NOVEL SERUM BIOMARKER INDUCED BY ARPI TREATED PROSTATE CANCER AND ENRICHED IN LINEAGE PLASTICITY WITH BRN2 HIGH	14
Urologic Heterodoxy Leads to Discovery	14
Reply by Authors	14
Size Matters, at Least Sometimes…	14
PD36-05 DEEP LEARNING PREDICTIVE MODEL FOR PROSTATE CANCER RECURRENCE USING CLINICAL AND HISTOLOGICAL DATA FROM THE TCGA DATABASE	14
IP14-06 TUMOROID AND GENOMIC MODELING OF LOW GRADE INTERMEDIATE RISK BLADDER CANCER TO PREDICT INTRAVESICAL CHEMOTHERAPY RESPONSE	13
V04-08 BREAKING BARRIERS IN ROBOTIC SURGERY: THE EFFICIENCY AND SAFETY OF LOW-COST, SINGLE-PORT EXTRAPERITONEAL SINGLE PORT ROBOTIC ASSISTED RADICAL PROSTATECTOMY	13
V02-12 PSYCHOGENIC URINARY INCONTINENCE: DA VINCI XI ROBOT-ASSISTED HEMINEPHROURETERECTOMY FOR COMPLETE DUPLEX KIDNEY WITH ECTOPIC URETERAL DRAINAGE	13
MP26-06 DOES IT REALLY MATTER? OUTCOMES OF SCROTAL EXPLORATION FOR TESTICULAR TORSION PERFORMED BY PEDIATRIC UROLOGISTS VS. ADULT UROLOGISTS	13
V15-06 SURGICAL MANAGEMENT OF TRAUMATIC INJURY IN A PEDIATRIC DUPLICATED COLLECTING SYSTEM	13
IP23-11 IMPACT OF ASPIRIN INTAKE ON BIOCHEMICAL RECURRENCE RATES IN HIGH-RISK PATIENTS FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A MULTICENTER RETROSPECTIVE COHORT STUDY	13
PD32-10 AUTOMATED NEPHROMETRY SCORES THROUGH DIRECT PREDICTION OF EACH COMPONENT	13
HF02-20 UROLOGY’S 20TH CENTURY BATTLE: SECURING ITS PLACE IN THE CLINIC AND CURRICULUM	13
IP17-31 INITIAL EXPERIENCE OF 10 CASES WITH NOVEL EXTRA-PERITONEAL MULTIPORT ROBOT-ASSISTED KIDNEY TRANSPLANT (eRAKT): A PROPENSITY-MATCHED COMPARISON WITH THE TRANSPERITONEAL APPROACH	13
GG03-16 COMPARATIVE ANALYSIS OF PROSTATE VOLUME MEASUREMENT METHODS FOR PSA DENSITY: DEEP LEARNING-BASED AUTOSEGMENTATION IN MR/TRUS FUSION TARGETED PROSTATE BIOPSY	13
PD08-10 COLLECTIVE OPTILUME BPH 2-YEAR CLINICAL OUTCOMES: COMBINED EXPERIENCE FROM THE PIVOTAL PINNACLE AND EVEREST PROSPECTIVE CLINICAL STUDIES	13
IP07-26 CORRELATION BETWEEN MAYO ADHESIVE PROBABILITY SCORE (MAP) AND SURGICAL OUTCOMES IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY	13
IP09-15 MANDATORY RESEARCH YEAR IN PEDIATRIC UROLOGY FELLOWSHIP TRAINING: PERCEPTIONS OF THE CURRENT WORKFORCE	13
MP11-19 MEN WITH DIAGNOSED HAIR LOSS ON FIVE-ALPHA REDUCTASE INHIBITORS DO NOT HAVE DECREASED INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA OR PROSTATE CANCER OVER A 20-YEAR PERIOD	13
V12-03 ROBOT ASSISTED URETEROPLASTY USING VESICAL MUCOSA GRAFT: OUR INITIAL EXPERIENCE	13
PD32-11 PREOPERATIVE PREDICTORS OF ADVERSE PATHOLOGY AND RECURRENCE-FREE SURVIVAL FOR PATIENTS WITH RENAL MASSES	13
IP27-02 THE ROLE OF SQUAMOUS CELL CARCINOMA ANTIGEN AND INFLAMMATORY MARKERS IN THE PROGNOSIS OF PENILE SQUAMOUS CELL CARCINOMA	13
IP27-04 PROSPECTIVE COTRIMS (COLOGNE TRIAL OF RETROPERITONEAL LYMPHADECTOMY IN METASTASTIC SEMINOMA) TRIAL – FINAL RESULTS	13
PD08-02 LONG-TERM OUTCOMES OF AQUABLATION FOR BENIGN PROSTATIC HYPERPLASIA: WATER, WATER II, OPEN WATER, FRANCAIS WATER, AND JAPAN PMS STUDIES	13
IP09-06 CLINICAL SIGNIFICANCE AND PROGNOSIS OF LOWER POLE HYDRONEPHROSIS FOLLOWING PROXIMAL URETEROURETEROSTOMY IN PEDIATRIC PATIENTS WITH DUPLEX SYSTEM	13
MP11-02 RESULTS FROM THE CLEAR RCT SUGGEST FACTORS CORRESPONDING TO EARLY PATIENT SATISFACTION ARE BETTER FOLLOWING UROLIFT PUL VS. REZUM WVTT	13
MP15-01 SEX-BASED DIFFERENCES OF SOMATIC MUTATIONS IN CAUCASIAN BLADDER CANCER POPULATION	13
PD08-01 GLOBAL AQUABLATION EXPERIENCE FROM THE ICARUS (INTERNATIONAL COLLABORATIVE AQUABLATION RESEARCH UROLOGY SOCIETY) DATABASE: LARGEST COHORT ASSESSING EFFICACY AND SAFETY IN BENIGN PROSTATIC HYPE	13
MP28-10 IMPACT OF CYTOREDUCTIVE NEPHRECTOMY ON IMMUNE CHECKPOINT INHIBITOR THERAPY: TREATMENT OUTCOMES OF IMMUNE INHIBITORS COMBINATION THERAPIES FOR METASTATIC RENAL CELL CARCINOMA WITH PRIMARY KIDNE	12
IP10-19 EXPLORING THE PREVALENCE OF POLYCYTHEMIA AMONG MEN IN TESTOSTERONE THERAPY	12
IP20-22 BEYOND THE CONVENTIONAL APPROACH: PREPROCEDURAL CAUDAL VS. POSTPROCEDURAL PENILE BLOCKS FOR PEDIATRIC UROLOGIC SURGERY PAIN MANAGEMENT IN PENILE SURGERIES	12
PD06-01 INNOVATIVE BIOMARKERS: SERUM ANDROSTENEDIONE AND STEROID RATIOS AS PREDICTORS OF SPERM RETRIEVAL IN NON-OBSTRUCTIVE AZOOSPERMIA	12
IP18-06 INFECTION FOLLOWING INFLATABLE PENILE PROSTHESIS PLACEMENT: A REAL-WORLD COMPARISON OF DEVICE SELECTION AND PATIENT CHARACTERISTICS	12
IP20-12 A DIAGNOSTIC SCORING SYSTEM TO DIFFERENTIATE TESTICULAR TORSION FROM TORSION OF THE APPENDIX TESTIS IN CHILDREN	12
V10-04 A MODIFIED TECHNIQUE FOR DOUBLE DISTAL CORPORAL ANCHORING STITCH IN THE MANAGEMENT OF LATERAL PENILE PROSTHESIS CYLINDER EXTRUSION	12
IP10-18 DOES KIDNEY TRANSPLANTATION IMPROVE ERECTILE FUNCTION? A PROSPECTIVE COHORT ANALYSIS OF END-STAGE RENAL DISEASE PATIENTS PRE AND POST KIDNEY TRANSPLANTATION IN MEXICO	12
MP24-08 BODY ROUNDNESS INDEX, A NOVEL OBESITY METRIC, AND ITS RELATIONSHIP WITH STRESS URINARY INCONTINENCE IN A POPULATION-BASED COHORT	12
IP27-40 CARE EXPERIENCE AND SUPPORT NEEDS OF TESTICULAR CANCER SURVIVORS: A QUALITATIVE STUDY	12
IP27-31 EFFICACY OF TRIPLE TRACER TECHNIQUE (TC 99 RADIOCOLLOID, INDOCYANINE GREEN, AND BLUE DYE) VERSUS DUAL DYE TECHNIQUE (INDOCYANINE GREEN, METHYLENE BLUE) FOR SENTINEL NODE BIOPSY IN CLINICALLY N	12
PD21-04 COMPARATIVE ANALYSIS OF LEARNING CURVES IN ENDOSCOPIC PROSTATE RESECTION AND ENUCLEATION WITH LASER DURING UROLOGY RESIDENCY: IS ENDOSCOPIC PROSTATE ENUCLEATION TRAINING EXCLUSIVE FOR EXPERTS?	12
IP20-02 HOW BLADDER EXSTROPHY AFFECTS MOTHERS' QUALITY OF LIFE, RESILIENCE, AND MENTAL HEALTH: A COMPARISON OF SINGLE-CHILD AND MULTIPLE-CHILD FAMILIES	12
IP06-27 ANALYSIS OF GENETIC TESTING IN KIDNEY STONE DISEASE: A SINGLE-INSTITUTIONAL ANALYSIS	12
MP37-18 IS IT WORTH USING THE COMPREHENSIVE COMPLICATION INDEX OVER THE CLAVIEN-DINDO CLASSIFICATION IN ELDERLY PATIENTS WHO UNDERWENT PERCUTANEOUS NEPHROLITHOTOMY?	12
MP14-15 IMPACT OF CYTOREDUCTIVE NEPHRECTOMY AND TIMING OF SYSTEMIC THERAPY ON OVERALL SURVIVAL IN METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA	12
IP27-24 OSTEOPOROSIS AMONGST TESTICULAR CANCER SURVIVORS: LONG TERM FOLLOW-UP OF THE VETERANS AFFAIRS HEALTH SYSTEM	12
UCF-13 ENDOUROLOGIC NEEDS ASSESSMENT TOOL: EVALUATING GLOBAL NEEDS AND BARRIERS FOR ENDOSCOPIC UROLOGICAL PROCEDURES	12
IP08-28 CLINICAL OUTCOMES COMPARING MINI VERSUS STANDARD TUBELESS PERCUTANEOUS NEPHROLITHOTOMY: A MULTI-INSTITUTIONAL RANDOMIZED CONTROLLED TRIAL FROM THE EDGE CONSORTIUM	12
PD26-11 RENAL MASS BIOPSY FOR SMALL RENAL MASSES: A SINGLE-CENTER 20-YEAR EXPERIENCE	12
V10-06 A NOVEL TECHNIQUE FOR DIRECT VISUALIZATION OF INFLATABLE PENILE PROSTHESIS RESERVOIR PLACEMENT USING A SINGLE-INCISION PENOSCROTAL APPROACH	12
MP37-03 HIGH DEDUCTIBLE HEALTH PLAN ENROLLMENT SIGNIFICANTLY DECREASES PROSTATE CANCER SCREENING	12
IP03-39 BENEFITS OF HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) OVER TRANSURETHRAL RESECTION (TURP) FOR BLADDER OUTLET OBSTRUCTION (BOO) IN PATIENTS WITH PROSTATE CANCER: A PROPENSITY SCORE-MATC	12
PD38-09 NEDD4-MEDIATED UBIQUITINATION OF GPX4: A KEY PATHWAY IN HIGH GLUCOSE-INDUCED FERROPTOSIS IN CORPUS CAVERNOSUM SMOOTH MUSCLE CELLS	12
PD39-09 SNM LEAD SENSING: SACRAL EVOKED RESPONSES ACROSS STANDARD THERAPY PROGRAMS	12
IP14-07 THERMOSENSITIVE LIPOSOMAL DOXORUBICIN COMBINED WITH HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY FOR TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER	12
PD27-05 INCREASING RESIDENT DIVERSITY: A MULTI-FACETED APPROACH TO INCREASING RESIDENCY PROGRAM DIVERSITY	11
IP09-38 IS THE SPECTRUM OF POSTERIOR URETHRAL VALVES (PUV) SEVERITY DETERMINED BY AGE AT PRESENTATION?	11
MP05-08 A NOVEL URODYNAMIC SCORING SYSTEM FOR EVALUATING CONTINENCE QUALITY OUTCOMES OF TOTALLY INTRACORPOREAL ROBOTIC ORTHOTOPIC ILEAL NEOBLADDERS AT MID-TERM FOLLOW-UP: RESULTS OF A PROSPECTIVE MULT	11
IP26-14 THERAPEUTIC TARGETING OF ARHGEF2 -RAC1 SIGNALING FOR NEUROENDOCRINE PROSTATE CANCER	11
IP21-14 DEFINING THE OPTIMAL PERI-LESIONAL BIOPSY SCHEME IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITH POSITIVE MULTI PARAMETRIC MRI: RESULTS FROM A PROSPECTIVE PAIRED-COHORT STUDY	11
IP09-31 A RANDOMIZED CONTROL TRIAL EVALUATING PAIN OUTCOMES OF KETOROLAC ADMINISTRATION IN CHILDREN UNDERGOING	11
V15-09 ROBOTIC ASSISTED MITROFANOFF AND MALONE: A SPLIT APPENDIX APPROACH	11
GG02-28 UTILITY OF FRAILTY IN PREDICTING SEVERE ADVERSE EVENTS IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH UPFRONT DOCETAXEL OR DAROLUTAMIDE PLUS DOCETAXEL: A MULTICENTER RETROSPECTIV	11
MP31-09 THE INCIDENCE AND CLINICAL OUTCOMES FOR PATIENTS WITH CONCOMITANT FOURNIER'S GANGRENE AND PENILE CALCIPHYLAXIS	11
IP03-07 RETREATMENT RATES OF MINIMALLY INVASIVE SURGICAL THERAPIES FOR BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW	11
MP39-13 CLINICAL SIGNIFICANCE OF INTRADUCTAL CARCINOMA OF THE PROSTATE AFTER HIGH-DOSE-RATE BRACHYTHERAPY WITH EXTERNAL BEAM RADIATION THERAPY: A SINGLE INSTITUTION SERIES AND AN UPDATED META-ANALYSIS	11
MP18-11 FERTILITY IN TRANSGENDER WOMEN: DO ALL HORMONE REGIMENS IMPACT SPERMATOGENESIS EQUALLY?	11
IP16-40 PATHOLOGIC FINDINGS AMONG RENAL MASSES IN SOLID ORGAN TRANSPLANT PATIENTS	11